Komori
Earnings presentation4401ADEKA CORPORATIONMaterials and Chemicals

Supplementary Materials for the Second Quarter Consolidated Financial Results for the Fiscal Year Ending March 2027

For the cumulative second quarter of the fiscal year ending March 2027, revenue increased 14.0% year on year and operating profit increased 40.0%. Chemicals and Life Sciences drove the increase in profit, while Food reported lower profit.

Worth reading
23Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
79
¥100 million (year-on-year increase in operating income)
Wording
Definitive
How definitive the wording is.

Contents of this document

Supplementary Materials to the Earnings SummarySecond quarter (interim period) of the fiscal year ending March 20272 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥2,231 billion+14.0%
Operating profit¥276 billion+40.0%
Results for the three months of the current quarter
Net Sales
¥1,061 billion
Operating profit
¥119 billion
What the company explained in this material
Key KPIsA metric the company considers important as a management benchmark.
  • Overseas revenue ratio55.2 %
    Year on year against the same period last yearUp 0.1 percentage points
  • Overseas revenue¥1,232 billion
    Year on year against the same period last yearUp ¥15.4 billion
  • Overseas revenue in Asia¥630 billion
    Year on year against the same period last yearUp ¥8.7 billion
  • Overseas revenue in the US, Europe, the Middle East and other regions¥602 billion
    Year on year against the same period last yearUp ¥6.7 billion
Segment results
Chemicals
Net Sales
¥1,260 billion+20.2%
Operating profit
¥203 billion+56.2%
Resin additives
Net Sales
¥575 billion+16.3%
Operating profit
¥80 billion+58.8%
Semiconductor materials
Net Sales
¥228 billion+44.8%
Operating profit
¥52 billion+53.5%
Environmental materials
Net Sales
¥456 billion+15.2%
Operating profit
¥71 billion+55.3%
Food
Net Sales
¥433 billion+6.5%
Operating profit
¥13 billion-35.7%
Life Sciences
Net Sales
¥500 billion+5.0%
Operating profit
¥54 billion+32.0%
Other
Net Sales
¥37 billion+52.0%
Operating profit
¥4 billion-1.7%
Contents of this document
ItemDetails
Document typeSupplementary Materials to the Earnings Summary
Fiscal Period CoveredSecond quarter (interim period) of the fiscal year ending March 2027
Net Sales¥2,231 billion (YoY +14.0%)
Operating profit¥276 billion (YoY +40.0%)
Results for the three months of the current quarterNet Sales ¥1,061 billion / Operating profit ¥119 billion
Segment resultsChemicals Net Sales ¥1,260 billion (YoY +20.2%) / Operating profit ¥203 billion (YoY +56.2%) / Resin additives Net Sales ¥575 billion (YoY +16.3%) / Operating profit ¥80 billion (YoY +58.8%) / Semiconductor materials Net Sales ¥228 billion (YoY +44.8%) / Operating profit ¥52 billion (YoY +53.5%) / Environmental materials Net Sales ¥456 billion (YoY +15.2%) / Operating profit ¥71 billion (YoY +55.3%) / Food Net Sales ¥433 billion (YoY +6.5%) / Operating profit ¥13 billion (YoY -35.7%) / Life Sciences Net Sales ¥500 billion (YoY +5.0%) / Operating profit ¥54 billion (YoY +32.0%) / Other Net Sales ¥37 billion (YoY +52.0%) / Operating profit ¥4 billion (YoY -1.7%)
Key KPIsIndicator name Overseas revenue ratio / Value 55.2 % / Year on year against the same period last year Up 0.1 percentage points, Indicator name Overseas revenue / Value ¥1,232 billion / Year on year against the same period last year Up ¥15.4 billion, Indicator name Overseas revenue in Asia / Value ¥630 billion / Year on year against the same period last year Up ¥8.7 billion, Indicator name Overseas revenue in the US, Europe, the Middle East and other regions / Value ¥602 billion / Year on year against the same period last year Up ¥6.7 billion
Items this document does not state (24)
Ordinary incomeNet incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesFull-year earnings forecastProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&ANew initiatives

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The materials show changes in revenue and operating profit by segment but do not explain the specific reasons for those changes.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Materials for the Second Quarter Consolidated Financial Results for the Fiscal Year Ending March 2027 | ADEKA CORPORATION (4401) timely disclosure | Komori